Russell Skibsted, Chief Financial Officer at AEOLUS PHARMACEUTICALS, INC. (AOLS), bought 7,027 shares at $0.24 ($2K) on 2012-05-23, disclosed to the SEC on 2012-05-23.
Open-market purchase of $2k AOLS by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| PCSA | BUY | 2026-06-01 | $6K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $6K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $6K | — | Filing → |